A phase II multicenter, double-blind, randomised trial to compare anastrozole plus gefitinib with anastrozole plus placebo in post-menopausal women with hormone recptor positive metastatic breast cancer. - Cristofanilli,M.; Valero,V.; Mangalik,A. (Proc Am Soc Clin Oncol, 2008)